Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Rullan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nature Cell Biology|June 20, 2020
Author Correction: STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapyEsther N Arwert, Emma L Milford, Antonio Rullan, et al.
Cancer Treatment Reviews|May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectivesPablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.
Life Science Alliance|January 28, 2021
A FIJI macro for quantifying pattern in extracellular matrixEsther Wershof, Danielle Park, David J Barry, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 23, 2024
Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01)Antonio Rullan, Juan A Marín-Jiménez, Alicia Lozano, et al.
Elife|March 9, 2023
Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinomaTakuya Kato, Robert P Jenkins, Stefanie Derzsi, et al.
Frontiers in Oncology|January 18, 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignanciesPablo Nenclares, Adrian Larkeryd, Floriana Manodoro, et al.
Iscience|September 12, 2024
Cancer cell - Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinomaGiovanni Giangreco, Antonio Rullan, Yutaka Naito, et al.
Nature Metabolism|April 27, 2026
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasionTimothy Budden, Noah Palombo, Shilpa Gurung, et al.
Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.
Journal for Immunotherapy of Cancer|February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor modelsEneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Cell Biology|June 20, 2020
Author Correction: STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapyEsther N Arwert, Emma L Milford, Antonio Rullan, et al.
Cancer Treatment Reviews|May 2, 2024
Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectivesPablo Jiménez-Labaig, Antonio Rullan, Irene Braña, et al.
Life Science Alliance|January 28, 2021
A FIJI macro for quantifying pattern in extracellular matrixEsther Wershof, Danielle Park, David J Barry, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 23, 2024
Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01)Antonio Rullan, Juan A Marín-Jiménez, Alicia Lozano, et al.
Elife|March 9, 2023
Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinomaTakuya Kato, Robert P Jenkins, Stefanie Derzsi, et al.
Frontiers in Oncology|January 18, 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignanciesPablo Nenclares, Adrian Larkeryd, Floriana Manodoro, et al.
Iscience|September 12, 2024
Cancer cell - Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinomaGiovanni Giangreco, Antonio Rullan, Yutaka Naito, et al.
Nature Metabolism|April 27, 2026
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasionTimothy Budden, Noah Palombo, Shilpa Gurung, et al.
Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.
Journal for Immunotherapy of Cancer|February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor modelsEneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Pageof 3